Monoclonal Antibody Administration - On Demand

Recorded On: 11/07/2023

Monoclonal antibodies (mAbs) have become a cornerstone of treatment in various therapeutic areas, especially within home and alternate site infusion settings. As their approval rates continue to rise, nurses play a pivotal role in ensuring positive patient outcomes before, during, and after the administration of these medications. This activity, designed for pharmacists, pharmacy technicians, and nurses will explore the development and manufacturing processes of monoclonal antibodies, providing a comprehensive understanding of how these medications are created and how these processes can help reduce the risk of adverse events.

Learning Objectives:

  1. Discuss the development of monoclonal antibodies (mAb) and the manufacturing processes designed to decrease adverse events.
  2. Recognize 2 signs that may indicate a patient has developed anti-drug antibodies.
  3. Identify nursing strategies to mitigate the risk of an infusion reaction.
  4. List the immediate steps in the management an acute infusion reaction.

This program was supported through an educational sponsorship from Naven Health Infusion Nursing.

NHIA General CE Information

Barbara McElroy, MSN, CRNI, VA-BC

Consultant

Consultant

Barbara McElroy, MSN, CRNI®, VA-BC™ is a clinical educator with 3 decades of experience in infusion and oncology nursing. She is an active contributor, writer, and speaker for multiple professional organizations with expertise in standards of care, evidence-based practice, and quality improvement initiatives. Barbara is an experienced nursing faculty in both pre and post-license BSN programs; a director of an LPN IV certification program; and provides expertise in the standard of care in legal cases. Barbara divides her time between the NH White Mountains and the Texas Hill Country.

NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

Barbara McElroy has no relevant financial relationships with ineligible companies to disclose.

Key:

Complete
Failed
Available
Locked
Monoclonal Antibody Administration
Open to view video.  |  60 minutes
Open to view video.  |  60 minutes
You must register to access.
Post Education Survey
8 Questions
8 Questions Monoclonal Antibody Administration INFUSION Article 1.0 CE JA4008389-0000-25-048-H01-P&T & 202907770-RN&RD
You must register to access.
Required to Claim CE
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available **PHARMACISTS & PHARMACY TECHNICIANS MUST SELECT THE BLUE "CLAIM CREDIT" BUTTON & ENTER YOUR DOB IN ORDER TO RECEIVE CE CREDIT** ________________________________________________________________________________________________________________________________________________________________________ NHIA adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, panelists, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Please note that the certificates printed from this platform are invalid as proof of continuing education (CE). For official documentation of CE credits, please print a paper statement of credit from your NABP e-profile.
You must register to access.